Sign in to add mentor
Albert Frey-Wyssling grad student 1960 ETH Zürich
 (Ueber das Redoxpotential lebender und absterbender Pflanzengewebe(Tabakverbräunung) )
James Frederick Bonner post-doc 1960-1963 Caltech


Sign in to add trainee
Adrian Bird grad student Edinburgh (Neurotree)
Meinrad Busslinger grad student Universität Zürich (Neurotree)
Michael Grunstein grad student Edinburgh
Bernhard Luscher grad student Universität Zürich (Neurotree)
Mary Lou Pardue post-doc (FlyTree)
Walter Schaffner post-doc Universität Zürich (FlyTree)
Stuart Gordon Clarkson post-doc 1970-1972 Edinburgh
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fritz JH, Brunner S, Birnstiel ML, et al. (2004) The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens Vaccine. 22: 3274-3284
Birnstiel ML. (2002) The dawn of gene isolation Gene. 300: 3-11
Spinelli G, Birnstiel ML. (2002) The modulator is a constitutive enhancer of a developmentally regulated sea urchin histone H2A gene Bioessays. 24: 850-857
Mattner F, Fleitmann JK, Lingnau K, et al. (2002) Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: Induction of potent and long-lasting T-cell responses against cancer antigens Cancer Research. 62: 1477-1480
Cotten M, Baker A, Birnstiel ML, et al. (2001) Preparation of adenovirus-polylysine-DNA complexes. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 12.3
Birnstiel ML. (1999) Moving from Zurich to Vienna: Up or down? Biological Chemistry. 380: 111-112
Schmidt W, Maass G, Buschle M, et al. (1997) Generation of effective cancer vaccines genetically engineered to secrete cytokines using adenovirus-enhanced transferrinfection (AVET). Gene. 190: 211-6
Stingl G, Bröcker EB, Mertelsmann R, et al. (1997) Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Journal of Molecular Medicine (Berlin, Germany). 75: 297-9
Schmidt W, Buschle M, Zauner W, et al. (1997) Cell-free tumor antigen peptide-based cancer vaccines Proceedings of the National Academy of Sciences of the United States of America. 94: 3262-3267
Buschle M, Schmidt W, Zauner W, et al. (1997) Transloading of tumor antigen-derived peptides into antigen-presenting cells Proceedings of the National Academy of Sciences of the United States of America. 94: 3256-3261
See more...